FDA-filed SPL labeling · retrieved through openFDA

Meloxicam

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis, with certain IV formulations approved for moderate-to-severe pain management in adults.

Brand names MobicMetacamLoxicomMeloxidylOstilox +8 more
Drug class ⓘ Nonsteroidal Anti-inflammatory Drug
Rx Forms 4 Routes Oral · Intravenous
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 131 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveMay 29, 2026
Clinical labels in scope ⓘ131
AvailabilityRx
Earliest approval/marketing year ⓘ2000
FDA-listed product records ⓘ385
Boxed warningYes
How we combine label and product data →
✓No current FDA shortage listed · checked Sep 24, 2026
Other forms & routes:
⭐ Meloxicam at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Meloxicam is an effective NSAID for osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis, with IV forms used for moderate-to-severe pain in adults. It carries serious risks for heart attack, stroke, and GI bleeding that apply from the very start of treatment, so it should always be used at the lowest effective dose for the shortest time necessary. Talk openly with your prescriber about your heart, stomach, kidney, and liver history before starting meloxicam.
⚠️ FDA Boxed Warning — the FDA’s strongest safety alert ▾

Meloxicam carries a serious FDA boxed warning about two major risks: heart events and stomach/intestinal bleeding.

Like all NSAIDs, meloxicam raises the risk of heart attack and stroke, which can be fatal. This risk can appear early in treatment and may increase the longer you take it. Meloxicam must not be used right before or after coronary artery bypass graft (CABG) heart surgery.

Meloxicam also raises the risk of serious bleeding, ulcers, and holes (perforation) in the stomach or intestines — any of which can be life-threatening. These problems can happen at any time and may occur without warning signs. Older adults and people who have had stomach ulcers or GI bleeding before are at the greatest risk.

Read the full warning on DailyMed →

📖 Meloxicam: Patient Information Guide

A plain-language walkthrough of Meloxicam — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Meloxicam is an NSAID approved for several inflammatory and pain conditions depending on the product and formulation.

  • Osteoarthritis — treated by meloxicam tablets, oral suspension, Zybic oral suspension, and meloxicam capsules
  • Rheumatoid arthritis — treated by meloxicam tablets and oral suspension (including Zybic)
  • Juvenile rheumatoid arthritis (JRA) in patients 2 years of age and older — treated by meloxicam oral suspension and Zybic oral suspension
  • Juvenile rheumatoid arthritis in patients weighing at least 60 kg — treated by meloxicam tablets
  • Moderate-to-severe pain in adults — managed by Qamzova (IV injection), Xifyrm (IV injection); these are not recommended when rapid pain relief is needed
⚙️How it works▾

Meloxicam blocks two enzymes called COX-1 and COX-2 (cyclooxygenase-1 and -2). These enzymes produce prostaglandins — chemical messengers that make nerves more sensitive to pain, cause inflammation, and contribute to fever. By reducing prostaglandin production in body tissues, meloxicam eases pain, swelling, and stiffness. The full mechanism is not completely understood, but inhibiting prostaglandin synthesis is considered the primary way it works.

💊How it's taken▾

Oral forms — tablets, capsules, and suspension — are taken by mouth once daily and can generally be taken with or without food. Always shake the oral suspension gently before use. IV formulations (Qamzova, Xifyrm) are given once daily as an intravenous injection in a healthcare setting only. Always use the lowest effective dose for the shortest time your condition requires, and follow your prescriber's specific instructions — do not switch between meloxicam formulations without guidance, as they are not interchangeable.

🤒Side effects — in detail▾

The most common side effects reported in clinical trials include:

  • Diarrhea
  • Indigestion or upset stomach (dyspepsia)
  • Nausea
  • Upper respiratory tract infection
  • Flu-like symptoms
  • Headache
  • Swelling (edema)
  • Abdominal pain

Serious reactions — including GI bleeding, heart attack, stroke, liver damage, severe allergic reactions, and dangerous skin reactions — can also occur and require immediate medical attention.

⚠️Warnings & precautions▾
  • Heart attack and stroke: Meloxicam raises the risk of serious cardiovascular events including heart attack and stroke, which can be fatal. This risk can begin early in treatment and may increase with longer use or higher doses. People with existing heart disease or risk factors face the highest absolute risk.
  • GI bleeding, ulcers, and perforation: Meloxicam can cause life-threatening stomach or intestinal bleeding, ulcers, or perforation — sometimes without any warning symptoms. Older adults and those with a history of ulcers or GI bleeding are at greatest risk.
  • Kidney and liver toxicity: Long-term use can harm the kidneys, and rare but serious liver injury has been reported. Monitor kidney and liver function, especially in at-risk patients.
  • Heart failure and high blood pressure: Meloxicam can worsen both conditions and may blunt the effectiveness of blood pressure medications and diuretics.
  • Serious skin reactions: Rare but life-threatening skin conditions such as Stevens-Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported. Stop the medication at the first sign of a rash.
  • Pregnancy risks: Meloxicam can harm an unborn baby, particularly after 20 weeks of pregnancy, and should be avoided from about 30 weeks onward.
🔀What it interacts with▾

Meloxicam interacts with several common medications — tell your prescriber and pharmacist everything you take:

  • Warfarin and other anticoagulants — combined use significantly raises the risk of serious bleeding
  • Aspirin — even low-dose aspirin combined with meloxicam increases GI bleeding risk; meloxicam is not a substitute for aspirin for heart protection
  • SSRIs and SNRIs (certain antidepressants) — may increase bleeding risk further when combined with meloxicam
  • ACE inhibitors, ARBs, and beta-blockers (blood pressure drugs) — meloxicam can reduce their effectiveness and, in vulnerable patients, worsen kidney function
  • Diuretics (water pills) — meloxicam may reduce their fluid-removing and blood pressure-lowering effects
  • Lithium — meloxicam can raise lithium blood levels, increasing the risk of lithium toxicity
  • Methotrexate — combination raises risk of serious toxicity including low blood counts and kidney problems
  • Cyclosporine — combination may increase kidney toxicity
  • Other NSAIDs or salicylates — do not take meloxicam with another NSAID; risk of GI toxicity increases with little added benefit

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Do not take meloxicam if you have ever had an allergic reaction — including hives, asthma attacks, or anaphylaxis — to aspirin or any other NSAID
  • Do not take meloxicam right before or after coronary artery bypass graft (CABG) surgery
  • Tell your doctor if you have a history of stomach ulcers, GI bleeding, heart disease, high blood pressure, heart failure, or kidney or liver problems
  • Pregnant women should avoid meloxicam from about 30 weeks of pregnancy onward; use between about 20 and 30 weeks should be limited to the lowest dose for the shortest time
  • Women who are having difficulty getting pregnant should tell their doctor — NSAIDs may reversibly delay ovulation
  • There are no human data on meloxicam in breast milk; discuss risks and benefits with your doctor if you are breastfeeding
  • Older adults are at higher risk for serious heart, GI, and kidney problems; start at the lowest possible dose and be monitored regularly
  • Patients with mild to moderate kidney impairment generally do not need a dose adjustment, but those on hemodialysis have a lower maximum daily dose limit; meloxicam is not recommended in severe renal impairment
  • Patients with mild to moderate liver impairment generally do not need a dose adjustment, but meloxicam should be used cautiously; it has not been well studied in severe liver impairment
🚑If you take too much▾

Taking too much meloxicam can cause drowsiness, nausea, vomiting, and stomach pain — these usually improve with supportive care. More serious but rare effects include GI bleeding, high blood pressure, acute kidney failure, and in severe cases, breathing problems or coma. There is no specific antidote; if you think someone has taken too much, call Poison Control at 1-800-222-1222 right away.

📡Pharmacodynamics — effects in the body▾

Meloxicam has pain-relieving (analgesic), anti-inflammatory, and fever-reducing (antipyretic) effects. It works by lowering prostaglandin levels in peripheral tissues — prostaglandins are chemical signals that make nerve endings more sensitive to pain and drive inflammation. By reducing these signals, meloxicam decreases pain sensitivity and swelling in affected joints and tissues.

🔬Pharmacokinetics — how your body processes it▾

When taken orally, meloxicam is well absorbed — peak blood levels are typically reached within about 4 to 6 hours, and the drug reaches steady-state levels in the body by around day 5 of regular use. It is heavily bound to plasma proteins (about 99%) and is broken down mainly in the liver, primarily through the CYP2C9 enzyme. The body clears meloxicam roughly equally through urine and stool (mostly as metabolites), with an elimination half-life of approximately 15 to 20 hours — meaning it stays in the body long enough to support once-daily dosing.

📦How to store it▾

Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) .

📄 Written from Meloxicam’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

113

Supplements & herbs that interact with Meloxicam

113 supplements and herbal products have documented interactions with Meloxicam in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 5
  • Moderate · 81
  • Minor · 27
Every supplement checked against Meloxicam — ranked by severity The full interaction hub: 5 major · 81 moderate · 27 minor · every one linked to its full report. Check Meloxicam against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

1

Nutrient depletion considerations

Meloxicam has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

See the full Meloxicam nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Meloxicam — the kind of thing our pharmacy team would talk through with you at the counter.

What conditions is meloxicam actually used to treat? ▾
Meloxicam treats pain and inflammation from osteoarthritis and rheumatoid arthritis in adults. It's also approved for juvenile rheumatoid arthritis in children — the oral suspension can be used in kids as young as 2, while tablets are for children weighing at least 60 kg. The capsule form is specifically for osteoarthritis pain. There are also IV versions (Qamzova, Xifyrm) that healthcare providers use in a clinical setting for moderate-to-severe pain in adults.
Can I take meloxicam with food, and does it matter what time of day I take it? ▾
Good news — you can take meloxicam with or without food, so whatever is easiest for you works fine. Taking it with a small snack can help if you find it bothers your stomach. It's taken once a day, so pick a time that's easy to remember and stick with it. If you're using the oral suspension, just give it a gentle shake before each dose.
What side effects should I expect, and which ones mean I should call someone? ▾
The most common side effects are stomach-related — things like diarrhea, indigestion, nausea, or abdominal discomfort. Upper respiratory infections and flu-like symptoms also show up fairly often. Those are unpleasant but manageable. The ones to act on quickly: chest pain, sudden weakness or slurred speech (possible stroke or heart attack), black or bloody stools or coffee-ground vomit (GI bleeding), severe skin reactions like blistering or peeling, yellowing of the skin or eyes (liver issues), or a severe allergic reaction with swelling and difficulty breathing. Any of those — go to the ER or call 911.
I take a blood thinner. Is it safe to use meloxicam too? ▾
This is a really important thing to discuss with your prescriber before starting meloxicam. When combined with blood thinners like warfarin, or even antidepressants that affect serotonin (like SSRIs), meloxicam significantly raises the risk of serious bleeding. The same goes for aspirin — taking them together increases GI bleeding risk. Your doctor may still decide the benefits outweigh the risks for you, but they'll want to monitor you closely. Never start or stop either medication without checking first.
Is meloxicam safe to take during pregnancy? ▾
Meloxicam needs to be used very carefully during pregnancy. From about 20 weeks onward it can affect your baby's kidneys, and from about 30 weeks it can cause a serious heart problem in the baby. The label recommends avoiding it at 30 weeks or later, and limiting use between 20 and 30 weeks to the lowest dose for the shortest time possible. If you're pregnant or planning to become pregnant, have this conversation with your doctor before taking meloxicam.
Does it matter which meloxicam product I use — can I just switch to whatever's cheapest? ▾
Actually, no — this is a common and important point. The different forms of meloxicam (tablets, capsules, oral suspension) are not interchangeable with each other, even if the milligram number looks the same. The capsule formulation in particular has different absorption characteristics than the tablets. Always take the specific form and brand your prescriber has prescribed, and check with your pharmacist before making any switch.
Is Meloxicam available over the counter? ▾
Meloxicam is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Meloxicam first available? ▾
Meloxicam has been available in the United States since at least 2000, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Meloxicam? ▾
Meloxicam is supplied by 84 manufacturers listed in the FDA NDC Directory, including Remedyrepack Inc., Bryant Ranch Prepack, A-S Medication Solutions.

💬 Answers drafted from Meloxicam’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

💊 How Meloxicam comes

Meloxicam is available in 4 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Tablet

By mouth
How this form is used
What it may be used for
  • Meloxicam tablets treat osteoarthritis
  • Meloxicam tablets treat rheumatoid arthritis
  • Meloxicam tablets treat juvenile rheumatoid arthritis in patients weighing at least 60 kg
Important instructions
  • Meloxicam tablets are taken by mouth once daily
  • Meloxicam tablets may be taken with or without food
  • Meloxicam tablets are not interchangeable with other meloxicam formulations even at the same milligram strength
  • Use the lowest effective dose for the shortest duration needed
Available strengths 2 strengths
343 FDA-listed product records ⓘ

Capsule

By mouth
Brands Vivlodex
How this form is used
What it may be used for
  • Meloxicam capsules are indicated for management of osteoarthritis pain
Important instructions
  • Meloxicam capsules are taken by mouth once daily
  • Meloxicam capsules are not interchangeable with other oral meloxicam formulations even at the same milligram strength
  • Use the lowest effective dose for the shortest duration needed
Available strengths 2 strengths
12 FDA-listed product records ⓘ

Oral suspension

By mouth
Brands Zybic
How this form is used
What it may be used for
  • Meloxicam oral suspension treats osteoarthritis
  • Meloxicam oral suspension treats rheumatoid arthritis
  • Meloxicam oral suspension and Zybic treat juvenile rheumatoid arthritis in patients 2 years of age and older
  • Zybic treats juvenile rheumatoid arthritis with dosing individualized by the child's weight
Important instructions
  • Shake the oral suspension gently before each use
  • Meloxicam oral suspension and Zybic may be taken without regard to timing of meals
  • Meloxicam oral suspension is not interchangeable with other meloxicam formulations even at the same milligram strength
  • Zybic is not interchangeable with other approved oral meloxicam formulations even at the same milligram strength
Available strengths 1 strength
5 FDA-listed product records ⓘ

Injection

Into a vein
Brands Anjeso Qamzova Xifyrm
How this form is used
What it may be used for
  • Qamzova is indicated for management of moderate-to-severe pain in adults, alone or combined with non-NSAID pain relievers
  • Xifyrm is indicated for management of moderate-to-severe pain in adults, alone or combined with non-NSAID pain relievers
  • Qamzova and Xifyrm are not recommended alone when rapid pain relief is required due to delayed onset of action
Important instructions
  • Qamzova and Xifyrm are given by intravenous injection in a healthcare setting — not for home use
  • Patients must be well hydrated before receiving Qamzova or Xifyrm to reduce the risk of kidney toxicity
  • Use for the shortest duration consistent with individual treatment goals
  • A short-acting non-NSAID pain reliever may be needed if Qamzova or Xifyrm does not provide adequate relief for the full dosing interval
Available strengths 1 strength
4 FDA-listed product records ⓘ

📊 Meloxicam across the U.S. market

How Meloxicam appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

4
Dose forms ⓘ
84
Manufacturers
6
Brand names
385
FDA-listed product records ⓘ
2000
First marketed ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (21) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

Remedyrepack Inc.10%
Bryant Ranch Prepack9%
A-S Medication Solutions7%
PD-Rx Pharmaceuticals, Inc.5%
Advanced Rx of Tennessee, LLC5%
Lupin Pharmaceuticals, Inc.4%
Other makers60%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Meloxicam is used

A general measure of how commonly Meloxicam is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Meloxicam is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

3,321,801
Medicaid prescriptions filled (Q1–Q4 2025)
$32.5M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Meloxicam prescribed? Of the 1,597 medications we measure, Meloxicam ranks #64 by Medicaid prescriptions — more than 96% of them.

Where Meloxicam ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5

Utilization by Meloxicam product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 15 mg oral tablet is the most-dispensed Meloxicam product — about 72% of these Medicaid prescriptions.

meloxicam 15 MG Oral Tablet Most dispensed

2,390,639 Medicaid prescriptions (Q1–Q4 2025) 72% of Meloxicam prescriptions shown $19.2M gross reimbursement (before rebates) ≈ $8.01 per prescription (gross)

Summed across the 11 of 409 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 152695

meloxicam 7.5 MG Oral Tablet

919,326 Medicaid prescriptions (Q1–Q4 2025) 28% of Meloxicam prescriptions shown $7.6M gross reimbursement (before rebates) ≈ $8.32 per prescription (gross)

Summed across the 12 of 354 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 311486

meloxicam 10 MG Oral Capsule

6,998 Medicaid prescriptions (Q1–Q4 2025) <1% of Meloxicam prescriptions shown $2.7M gross reimbursement (before rebates) ≈ $384 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1722357

meloxicam 5 MG Oral Capsule

4,838 Medicaid prescriptions (Q1–Q4 2025) <1% of Meloxicam prescriptions shown $3.1M gross reimbursement (before rebates) ≈ $632 per prescription (gross)

Summed across the 2 of 5 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1722349

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Meloxicam, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 27 of 773 listed Meloxicam NDCs with Medicaid activity.

🔍 Compare Meloxicam products

A representative set of FDA-listed product records for Meloxicam — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 385 products — FDA National Drug Code Directory. See every product, package size and price: browse all 385 Meloxicam NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Meloxicam RxCUI 41493 7 dose forms · 12 strengths
  1. Dose form (SCDF) Disintegrating Oral Tablet RxCUI 2118580 In current FDA listings
    Clinical drug / strength (SCD) 7.5 MG RxCUI 2118589 15 MG RxCUI 2118581
  2. Dose form (SCDF) Injectable Solution RxCUI 372752 In current FDA listings
    Clinical drug / strength (SCD) 5 MG/ML RxCUI 1086707
  3. Dose form (SCDF) Injection RxCUI 2281105 In current FDA listings
    Clinical drug / strength (SCD) 1 ML meloxicam 30 MG/ML RxCUI 2281106
  4. Dose form (SCDF) Oral Capsule RxCUI 446251 In current FDA listings
    Clinical drug / strength (SCD) 5 MG RxCUI 1722349 10 MG RxCUI 1722357
  5. Dose form (SCDF) Oral Suspension RxCUI 597405 In current FDA listings
    Clinical drug / strength (SCD) 0.5 MG/ML RxCUI 1091876 1.5 MG/ML RxCUI 597406
  6. Dose form (SCDF) Oral Tablet RxCUI 372754 In current FDA listings
    Clinical drug / strength (SCD) 7.5 MG RxCUI 311486 15 MG RxCUI 152695
  7. Dose form (SCDF) Rectal Suppository RxCUI 372753 No current FDA listing
    Clinical drug / strength (SCD) 7.5 MG RxCUI 226923 15 MG RxCUI 152694

Look up RxCUI 41493 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Mobic Metacam Loxicom Meloxidyl Ostilox Vivlodex Qmiiz Alloxate Anjeso Meloxivet Xifyrm Qamzova Zybic

🏭 Manufacturers & labelers

Remedyrepack Inc. 31 Bryant Ranch Prepack 28 A-S Medication Solutions 22 PD-Rx Pharmaceuticals, Inc. 16 Advanced Rx of Tennessee, LLC 15 Lupin Pharmaceuticals, Inc. 12 Aphena Pharma Solutions - Tennessee, LLC 12 Proficient Rx LP 8 St. Mary's Medical Park Pharmacy 8 RedPharm Drug, Inc. 7 Aurobindo Pharma Limited 7 NuCare Pharmaceuticals,Inc. 6 Advanced Rx Pharmacy of Tennessee, LLC 6 Golden State Medical Supply, Inc. 6 XLCare Pharmaceuticals, Inc. 6 Direct_Rx 6 Direct Rx 6 Cipla USA Inc. 6 AiPing Pharmaceutical, Inc 6 Carlsbad Technology, Inc. 6 Asclemed USA, Inc. 6 Zydus Pharmaceuticals USA Inc. 6 AvPAK 6 NuCare Pharmaceuticals, Inc. 6

…and 16 more on the FDA NDC directory.

RxNorm drug class

Meloxicam belongs to the Nonsteroidal Anti-inflammatory Drug class.

Pharmacologic class Nonsteroidal Anti-inflammatory Drug
Drug family (ATC) Amides, Oxicams
How it works Cyclooxygenase Inhibitors

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective May 29, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Meloxicam.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Meloxicam after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
131
NDC products indexed
385
Distinct labelers/manufacturers represented
84
Linked representative label ⓘ
Avondale Pharmaceuticals, LLC
Linked label effective
May 29, 2026
Composite sections available
25
Linked SPL Set ID
4ddf5a4d-8e84-419d-8e3a-c91b85501885
Linked SPL Document ID
fa52a9ca-fe56-49c3-8029-2b7d2e522d4f
Open the linked representative label on DailyMed ↗
NDC package records associated with this linked SPL 1

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 131 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Avondale Pharmaceuticals, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.